Immunotherapy has Emerged as an Effective Treatment for Patients with Blood Cancer States Dr. Sharat Damodar, Narayana Health City

Bengaluru | Saturday | 28th May, 2022

Summary:

Bengaluru, Karnataka, India (NewsVoir) Blood cancer has long been regarded as a death sentence.

However over the last 2 decades there has been considerable progression in the treatment of blood cancer with survival rates ranging from 60 to 80% in various subtypes.

On the occasion of World Blood Cancer Day let’s understand in detail some of the curative options.

There are 2 types of blood cancers - acute leukemia and chronic leukemias.

Acute leukemia can be lymphoid or myeloid.

With the progress in various chemotherapy regimens the cure rate in pediatric acute lymphatic leukemia has been as high as 80 to 90% in western literature, but the numbers are lower in our country, it is around 60 to 80%.

There are various reason for this starting from delay in diagnosis, to higher infection rates to disease biology and pharmacogenetics.